Dantrolene sodium approved for malignant hyperthermia.
D003620:Dantrolene / Q000627:therapeutic use*; D006801:Humans; D008305:Malignant Hyperthermia / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D003620:Dantrolene